Destruction of Controlled Drugs by Authorised Witnesses - Standard Operating Procedure

Similar documents
HP0557, LD 821, item 2, 124th Maine State Legislature, Amendment C "A", Filing Number H-625, Sponsored by

MEDICINES AND RELATED SUBSTANCES AMENDMENT BILL

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

BERMUDA PHARMACY AND POISONS ACT : 26

CHAPTER 40A DRUG SERVICE

The Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005

Medicines and Related Substances Control Act 13 of 2003 section 44

CHAPTER 34:02 ANTIBIOTICS ACT ARRANGEMENT OF SECTIONS

TITLE 15 LEGISLATIVE RULE BOARD OF PHARMACY SERIES 2 RULES OF THE BOARD OF PHARMACY FOR THE UNIFORM CONTROLLED SUBSTANCES ACT

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

2010 No. 231 HEALTH CARE AND ASSOCIATED PROFESSIONS. The Pharmacy Order 2010

BELIZE ANTIBIOTICS ACT CHAPTER 33 REVISED EDITION 2000 SHOWING THE LAW AS AT 31ST DECEMBER, 2000

THE STATUTES OF THE REPUBLIC OF SINGAPORE BIOLOGICAL AGENTS AND TOXINS ACT (CHAPTER 24A)

BIOLOGICAL AGENTS AND TOXINS ACT (CHAPTER 24A)

Version control of clinical trial documents for HEY-sponsored CTIMPs

REPUBLIC OF SOUTH AFRICA

Patient Information and Consent

The Litter Control Act

Florida Senate SB 518 By Senator Saunders

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

Reproduced by Sabinet Online in terms of Government Printer s Copyright Authority No dated 02 February 1998 STAATSKOERANT, 22 JULIE 2011

(14 November 1997 to date) HAZARDOUS SUBSTANCES ACT 15 OF (Gazette No. 3834, No. 550 dated 4 April See Act for commencement dates.

REPUBLIC OF SINGAPORE GOVERNMENT GAZETTE ACTS SUPPLEMENT Published by Authority NO. 37 [2005] FRIDAY, DECEMBER 9

POCKET REFERENCE DRUG SAMPLE DISTRIBUTION: SELECT FEDERAL LAWS AND REGULATIONS

Schedule of Decisions Reserved to the Board and the Scheme of Delegation

General Legal Requirements A guide for pharmacists in Northern Ireland 2010 Edition. Non-Medicinal Poisons

CODING: Words stricken are deletions; words underlined are additions. hb e1

Guidance Document (Medical Devices and Diagnostic Division)

OHIO MEDICAID SUPPLEMENTAL REBATE AGREEMENT

HOUSE AMENDMENT Bill No. HB 5511 (2012) Amendment No. CHAMBER ACTION

CHAPTER House Bill No. 5511

(1 March to date) HAZARDOUS SUBSTANCES ACT 15 OF (Gazette No. 3834, No. 550 dated 4 April See Act for commencement dates.

compounded or made by or under the direct and personal supervision of a

CHAPTER 53 PHARMACY AND POISONS ORDINANCE ARRANGEMENT OF SECTIONS PART I PRELIMINARY PART II PHARMACY

GENERIC EQUIVALENT DRUG LAW Act of Nov. 24, 1976, P.L. 1163, No. 259 AN ACT Relating to the prescribing and dispensing of generic equivalent drugs.

S U P P L E M E N T No. 2 TO THE SOVEREIGN BASE AREAS GAZETTE No of 13th October 2006 L E G I S L A T I O N

IC Chapter 19. Drugs: Indiana Legend Drug Act

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

Section moves to amend H.F. No as follows: 1.2 Delete everything after the enacting clause and insert:

(Medical Devices Division) Guidance Document

COLLEGE OF NATUROPATHIC PHYSICIANS OF BRITISH COLUMBIA

Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Rules and Regulations

CHAPTER Committee Substitute for House Bill No. 4043

ANALYSIS. 30. Burden of proof. 36. Application of Customs Act Regulations. 38. Effect on Poisons Act Repeals. 1975, No.

PROJET DE LOI ENTITLED. The Medicines (Human and Veterinary) (Bailiwick of Guernsey) Law, 2008 * [CONSOLIDATED TEXT] NOTE

Supplementary Order Paper

COLLEGE OF OPTOMETRISTS OF BRITISH COLUMBIA. Bylaws

THE NATIONAL DRUG POLICY AND AUTHORITY STATUE, ARRANGEMENT OF SECTIONS. PART I-PRELIMINARY PROVISIONS. Section. 1. Short title. 2.

Consolidated text PROJET DE LOI ENTITLED. The Misuse of Drugs (Bailiwick of Guernsey) Law, 1974 [CONSOLIDATED TEXT] NOTE

STATE OF FLORIDA DEPARTMENT OF HEALTH

RADIATION PROTECTION ACT

UK RENAL PHARMACY GROUP CONSTITUTION AND TERMS OF REFERENCE

Public Health (Skin Penetration) Regulation 2000

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

2009 No. 183 NATIONAL HEALTH SERVICE. The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009

NC General Statutes - Chapter 90 Article 5D 1

Amendments to Healthcare Research

PRESCRIPTION MONITORING PROGRAM MODEL ACT 2010 Revision

PHARMACY ACT PHARMACY ACT 1967 (XI OF

(XI OF 1967) An act to establish Pharmacy Councils to regulate the practice of Pharmacy.

PHARMACY AND DRUG ACT

CHAPTER 11. PURCHASES AND SALES

STATUTORY INSTRUMENTS. S.I. No. 538 of 2007 MEDICINAL PRODUCTS (CONTROL OF WHOLESALE DISTRIBUTION) REGULATIONS 2007

THE ORISSA LEGAL METROLOGY (ENFORCEMENT) RULES, 2010

State of Florida Department of Business and Professional Regulation Division of Drugs, Devices, and Cosmetics

PART I PRELIMINARY MATTERS

ST CHRISTOPHER AND NEVIS CHAPTER 9.08 DRUGS (PREVENTION AND ABATEMENT OF THE MISUSE AND ABUSE OF DRUGS) ACT

1. Short title and application 2. Interpretation. 21. Regulations

ARRANGEMENT OF SECTIONS

The State Law and Order Restoration Council hereby enacts the following Law: Chapter I Title and Definition

GOVERNING BODY TERMS OF REFERENCE

Conditions of Licence for Allopathic Loan Licence Manufacturing

Misuse of Drugs Act 1971

The Pharmacy Act, 1996

No. R February internal rules" means the rules referred to in regulation 7; HAZARDOUS SUBSTANCES ACT, 1973 (ACT No.

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540 X 12 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC)

COLLEGE OF VETERINARIANS OF BRITISH COLUMBIA

Narcotic Drug Regulations (2018 Measures No. 1) Instrument 2018

Joint Commissioning Committee of the Cheshire Clinical Commissioning Groups Terms of Reference

SAFE IMPORTATION OF MEDICAL PRODUCTS AND OTHER RX THERAPIES ACT OF 2004 (SAFE IMPORT ACT) SECTION-BY-SECTION SEC. 1. SHORT TITLE.

Federal Law on Medicinal Products and Medical Devices

NHS England Standard Alternative Provider Medical Services Contract 2014/15

The Pharmacy and Pharmacy Disciplines Act

The Management of individuals by Witness Protection Units (WPUs) Standard Operating Procedures. Version Version 1.0 Summary

NHS England Standard General Medical Services Contract 2017/18

SENATE, No STATE OF NEW JERSEY. 215th LEGISLATURE INTRODUCED AUGUST 19, 2013

(9) Adequacy of electric electronic detection and alarm systems, if any, including use of supervised transmittal lines and standby power sources;

The Pharmacy and Pharmacy Disciplines Act

LAWS OF GUYANA. Medical Practitioners 3 CHAPTER 32:02 MEDICAL PRACTITIONERS ACT ARRANGEMENT OF SECTIONS PART I PRELIMINARY PART II

HEALTH AND PERSONAL SOCIAL SERVICES. Coming into operation... 6 October 1997

CHAPTER 327 THE UGANDA NATIONAL BUREAU OF STANDARDS ACT. Arrangement of Sections. Interpretation. Establishment and functions of the bureau.

Case 4:18-cv KGB Document 30 Filed 04/19/18 Page 1 of 21

NHS Bradford Districts CCG

Bank Note Paper Mill India Private Limited, Mysore. For any query, you may contact at Tel , Fax

HEARING HEARD IN PUBLIC

State Prescription Fraud Provisions

PRODUCTS: Single entity and combination ephedrine (EPH), pseudoephedrine (PSE) and phenylpropanolamine (PPA) products

For purposes of this chapter, the following words and phrases have the following meanings:

KINGDOM OF TONGA. PESTICIDES ACT OF 2001 (Section 22) THE PESTICIDES REGULATIONS 2001 ARRANGEMENT OF REGULATIONS

John R. McPherson, DDS, Secretary/Treasurer. Brenda Upton, RPh, Board Member Governor: Matthew H. Mead

Transcription:

Destruction of Controlled Drugs by Authorised Witnesses - Standard Operating Procedure Destruction of Controlled Drugs by Authorised Witnesses Standard Operating Procedure Version 1.3 Number of pages : 11 Date of Issue : January 2009 Date of Next Review: December 2011 Date of Authorisation : 3 rd March 2009 Authorised by : Policy Ratification Group (Sub Group of Healthcare Governance and Risk Committee) Distribution : PCT Intranet Site This SOP has been Equality Impact Assessed Post Responsible for Review: PCT Controlled Drug Accountable Officer PLEASE NOTE: Check that this document is the most current version of this policy you will find it on the PCT Intranet (V1.3) January 2009 (For Review December 2011) 1 of 11

Version Control Sheet Version Date Author Status Comment 1.3 January 2009 (V1.3) January 2009 (For Review December 2011) 2 of 11

Destruction of Controlled Drugs by Authorised Witnesses Standard Operating Procedure (V1.3) Introduction It is a legal requirement for stocks of Controlled Drugs (CDs) to be destroyed in the presence of an Authorised Witness. The witnessed destruction of stocks has, historically, been restricted to certain groups of individuals granted authority by the Home Office. The Shipman Enquiry has led to a wide ranging review of CD management. In recognition of the need for PCTs to manage witnessed destruction of CDs in a well regulated, safe and timely manner, the Home Office has extended the range of persons eligible to witness destruction and given the Accountable Officer (AO) of a PCT the power to appoint appropriate individuals as authorised witnesses from within the PCT/s for which they have responsibility. Purpose The safe and appropriate destruction of CD stock in compliance with current legislative requirements and good practice guidance. Scope This standard operating procedure (SOP) applies to witnesses authorised by the AO for the PCT and relates to the destruction of out of date or unwanted CD stock. Note - Some premises may also, from time to time, have Patient returns*. It is not a legal requirement for patient returns to be destroyed in the presence of an Authorised Witness. If, however, whilst attending to witness the destruction of stock CDs, the Authorised Witness may (at their discretion) also witness the destruction of patient returns. * Patient Returns = any CDs dispensed to and collected by an individual patient on prescription which are returned out of date or otherwise no longer required. It will explain how CDs should be destroyed in the presence of authorised witnesses. It will explain how any discrepancies/problems found during the destruction process should be addressed. All PCT appointed authorised witnesses must read this SOP and by signing the declaration in appendix 4, agree to abide by it. Note Please refer to appendix 3 for background information regarding CD register and Patient Return Record Book completion. Standard Operating Procedure Receiving Requests & Arranging Visits for the Destruction of CDs When a PCT clinical provider, Community Pharmacy*, GP Practice or other appropriate body has stock CDs requiring destruction they should contact the PCT Medicines Management Team Secretary (to allow effective monitoring of activity and re-direct requests as may be necessary). * NB! Some of the larger Community Pharmacy chains have there own internal Authorised Witnesses. These Companies should not approach the PCT to witness the destruction of CDs on their premises. If they do, the Pharmacy concerned should be directed to their Superintendent Pharmacist s Office, or other point of contact, for (V1.3) January 2009 (For Review December 2011) 3 of 11

further help (A list of Companies that have their own Authorised Witnesses is available). The MMT Secretary will notify one of the authorised witnesses who will contact the person/body making the request to arrange a mutually suitable date & time for destruction to take place. Note 1/ Authorised witnesses should not witness destruction of CDs for a GP Practice to whom they are providing Medicines Management Support or where they work at the time of destruction. 2/ Authorised witnesses should not act in that capacity within any Community Pharmacy premises in which they are currently also providing services as a Pharmacist. 3/ The CDs to be destroyed should have been appropriately recorded, marked and segregated as necessary prior to the visit. Additionally a denaturing kit/s must have been obtained by the stock holder and be available when the visit takes place*. Staff working for the stock holder will carry out all physical elements of the destruction process. We therefore recommend that those staff have appropriate Health & Safety training and any protective equipment/clothing necessary to safely handle the various drug formulations that are to be destroyed, is made available to them by their employer. *It may be prudent to check this at the time the appointment is arranged. Record Keeping Details of all CDs destroyed will be entered in the CD register in compliance with legislation (see appendix 1 for example entries. Please Note, some newer CD registers may contain additional columns to enable a record of the person collecting a CD prescription to be recorded. The presence of these additional columns does not however effect the requirements for recording destruction). If the authorised witness has any concerns, questions or comments regarding the destruction visit (eg. quantity to be destroyed does not balance, CD register entries are poorly recorded etc they should detail their concerns/findings on the Controlled Drug Destruction Notes form (see appendix 2). Note Comments should be discussed with the AO or their deputy as soon as possible. Procedure for Destruction of CDs On arrival at the premises the authorised witness will identify themselves, using their PCT ID badge (if they are not already known to staff). 1/ All parts of the process must take place in the presence of the Authorised Witness. It is neither the role nor responsibility of the Authorised Witness to assist with the actual destruction process (i.e. removal of products from packaging and adding to the DOOP kit/s). This must be done by staff employed by the stock holder. It is the responsibility of the staff and their employers, to ensure that they are adequately trained and protected as necessary (e.g. wearing gloves). 2/ CDs must be destroyed using a denaturing kit designed for that purpose. The only deviation is where large volumes of liquids are involved (see below). Note - CD/Drug Denaturing Kits include instructions for use, these must be followed to ensure effectiveness. (V1.3) January 2009 (For Review December 2011) 4 of 11

3/ The CDs quarantined for destruction should be removed from the CD cupboard and reconciled with the CD Register (CDR) and/or Patient Returns Record Book (PRRB). 4/ CDs should be added to the denaturing kit according to the process, described below. Order of adding products to kit; 1 st solid oral dose forms (e.g. tablets/capsules), powder containing injection vials/ampoules and transdermal patches, 2 nd small volume liquids (e.g. injection ampoules/vials), 3 rd large volume liquids* (e.g. oral liquids, larger volume injection vials). Note after emptying the liquid into the denaturing kit, the container should be rinsed once with water and this to, added to the kit. The empty container can then be discarded with normal waste. Processing products before adding to the kit Tablets and capsules should be removed from all packaging, injection ampoules/vials should be opened and the contents + all glass added to the granules, transdermal patches should be cut in two, or folded over onto themselves. * Liquids (other than the small volumes in ampoules/vials) should be added last and all at the same time. Note - Denaturing kits are available up to 2L capacity. If a large volume of liquid requires denaturing the stock holder may either use the larger kits or cat litter. If using cat litter a sufficient quantity must be used to fully adsorb the liquid added. Suitable containers to hold the cat litter must be provided by the stock holder. The cat litter in its container must be discarded in the clinical waste sharps bin. 5/ The CDs should be written out of the CDR and/or PRRB as they are added to the kit The entry must specify; the name, strength and form of the product, date, quantity destroyed, printed name & professional registration number of authorised witness followed by their signature, printed name and signature of the second witness and the balance remaining (see examples in appendix 1). 6/ For CD stock, the balance remaining should be reconciled with the CDR and signed by the persons witnessing destruction. 7/ Once ALL products being destroyed have been added to the kit, water should be added, as necessary*, in accordance with the kit manufacturers directions. *Note, if larger volume CD liquids are being destroyed their volume should be taken into account and the volume of water required adjusted accordingly. 8/ The used kit should then be put in the CD cupboard whilst the inactivation process is taking place. The CDs are now considered irretrievable and the responsibility of the authorised witness is complete. Note - the kit contents will form a gel within a few minutes and may become hot initially (this is normal). It may take up to 24 hours for the inactivation process to complete. 9/ After 24 hours the kit should be added to a standard clinical waste sharps bin for disposal by incineration. 10/ If necessary, ie if the authorised witness came across any issues or concerns during the destruction visit (eg. quantity to be destroyed does not balance, CD register entries are poorly recorded) they should detail their concerns/findings on the Controlled Drug Destruction Notes form (see appendix 2) and return this to the PCT AO. (V1.3) January 2009 (For Review December 2011) 5 of 11

Discrepancies Discrepancies that are not traced and corrected (e.g. a mathematical error within the CDR) at the time should be recorded in the CDR and by the Authorised Witness on the CD Destruction Record Notes form*. It is not the function of the Authorised Witness to investigate untraced discrepancies at the time of destruction. However, the Authorised Witness should make a detailed note of the discrepancy and feed it back to the Accountable Officer, or their deputy, within 2 working days. Staff of the organisation holding the CDs should refer to their internal procedures for follow up and resolution. * Note - The presence of discrepancies does not necessarily prevent the destruction of CDs from taking place. The Authorised Witness should consider the risks (if any) of not destroying the CDs during the visit, recording what has, or has not, been destroyed and include any relevant information on the CD Destruction Record Notes form (see appendix 2). Training and information The PCT will provide appropriate training for all Authorised Witnesses. The PCT will provide updates and where necessary additional training for all Authorised Witnesses as and when the need arises. (V1.3) January 2009 (For Review December 2011) 6 of 11

Appendix 1 Destruction Example page from an Intermediate Care CDR (these will be patient s own drugs ) Mr Apu Nahasa, Quik-E-Mart, Springfield NAME, FORM OF PREPARATION AND STRENGTH Morphine Sulphate 10mg MR Tablets.. 001 AMOUNT(S) OBTAINED Amount Date Received Serial No. of Requisition AMOUNTS ADMINISTERED Date Time Patient s Name Amount Given Given by (Signature) Witnessed by (Signature) STOCK BALANCE 45 17/5/07 Received from Mr A Nahasa, by Sig. 1, Sig. 2, 45 17/5/07 22:00 Apu Nahasa 1 Sig. 1 Sig. 2 44 18/5/07 10:00 Apu Nahasa 1 Sig. 1 Sig. 2 43 18/5/07 22:00 Apu Nahasa 1 Sig. 1 Sig. 2 42 22/5/07 14:20 42 Morphine Sulphate 10mg MR tablets destroyed Authorised Witness Name, Registration No. & Signature - Name & Signature of 2 nd Witness. Nil Example page from a Community Pharmacy/Dispensing Surgery CDR Drug Class Morphine Sulphate.. Brand MST Strength 10mg. Form MR Tablets. Date Obtained Supplied Balance Name, address of Authority to possess Name and registration Name of person Amount Name, address of Amount person or firm from Prescriber or license number of pharmacist collecting obtained person or firm supplied supplied whom obtained holder details supplying (and ID shown) 7/5/06 C/F from page 1 45 45 8/5/06 Mr Homer J Simpson, 742 Evergreen Terrace Springfield Dr Julius. Hibbert the Surgery, Springfield P Harmacist, 123456 Mrs Marge Simpson 10 35 9/5/07 35 tablets quarantined, out of date, awaiting destruction. 35 9/5/07 1/6/07 The Pharmacy Wholesalers. 60 95 35 out of date morphine sulphate 10mg MR tablets destroyed Authorised Witness Name, Registration No. & Signature - Name & Signature of 2 nd Witness. 60 Example page from a Patient Return Record Book Name Address Description of CDs Witnessed By Witnessed By Date BALANCE Of person to whom the CDs were dispensed Name, Form, Strength, Quantity (Signature) (Signature) Mr C Morphine Sulphate 10mg MR (MST) tablets 17/5/07 Montgomery Burns Manor, Springfield Sig. 1 Sig. 2 44 x 44, for destruction. Burns 22/5/07 44 Morphine Sulphate 10mg MR tablets destroyed Name & Signature of 1 st Witness Name & Signature of 2 nd Witness. Nil (V1.3) January 2009 (For Review December 2011) 7 of 11

Appendix 2 Authorised Witness Controlled Drug Destruction Notes NB! Patient identifiable information must not be included in these notes [the use of patient initials is acceptable if appropriate]. Date : Location : Visit Notes - for completion if required : Authorised Witness Signature: Please return to : PCT Accountable Officer, PCT,. (V1.3) January 2009 (For Review December 2011) 8 of 11

Appendix 3 General Information/Notes CD Registers; The format and requirements for CD registers are specified in Regulations 19, 20 and Schedule 6 of the Misuse of Drugs Regulations 2001 as amended. Currently the register must: Be bound (not loose-leaved) or a computerised system which is in accordance with best practice guidance Contain class sections for each individual drug Have the name of the drug specified at the top of each page Have the entries in chronological order and made on the day of the transaction or the next day Have the entries made on consecutive lines (no blank lines). Have the entries made in ink or otherwise so as to be indelible or in a computerised form in which every such entry is attributable and capable of being audited and is in accordance with best practice guidance endorsed by the Secretary of State under section 2 of the NHS Act 1977 Not have cancellations, obliterations or alterations; corrections must be made by a signed and dated entry in the margin or at the bottom of the page Be kept at the premises to which it relates and be available for inspection at any time. A separate register must be kept for each set of premises (for example, not just the main surgery) Be kept for a minimum of two years after the date of the last entry, once completed (Note - we recommend 11 years now as it is proposed that legislation is amended to require this) Not be used for any other purpose. The definition of a CD register in the 2001 Regulations was amended in November 2005 to allow (not require) the register to be held on a computerised system which complies with specified best practice guidance. The Regulations require that entries in computerised registers must be attributable and capable of being audited. At the time of writing there is no use of electronic CDRs locally that we are aware of. Community Pharmacies and PCT services will use specially designed, pre-printed CDRs obtained from approved suppliers. Some GP surgeries will do likewise, particularly Dispensing Practices. It is not however a legal requirement to use such registers and you may find that some Surgeries will have drawn up their own registers using a bound book and this is fine provided that they comply with legislation. For CDs received into stock the following details must be recorded in the CD register: The date on which the CD was received The name and address of the supplier, e.g. wholesaler, pharmacy The quantity received The name, form and strength of the CD. For CDs supplied to patients (via prescriptions), or to practitioners (via requisitions), the following details must be recorded in the CD register: The date on which the supply was made The name and address of the patient or practitioner receiving the CD Particulars of the authority of person who prescribed or ordered the CD The quantity supplied The name, form and strength in which the CD was supplied. Note - The 2001 Regulations were amended in July 2006 to make clear that the record keeping requirements of the CD Regulations are a minimum and do not prevent any person required to keep a CD register from including additional related information. (V1.3) January 2009 (For Review December 2011) 9 of 11

Patient Return Record Book Whilst there is currently no legal requirement to keep any records of patient returns, it is good practice and strongly recommended that records are kept and in practice this usually happens. It therefore also follows that there is no legal requirement for patient returns to be destroyed in the presence of an authorised witnessed, but this sometimes happens in practice. A dedicated Patient Returns Record Book should be used. There is no legally required format for this record, however it is recommended that such a book should be bound (not loose leafed), entries should be indelible, errors should not be erased but marked and a correcting entry and explanation made. They should contain the following details: Date of return Patient s name (if known) Address of the dispensing Pharmacy/Practice (if known) Drug details and quantity returned Signature of staff accepting the return and making the entry It is good practice for 2 people to witness the destruction of patient returned CDs, using a denaturing kit and recording the destruction in the Patient Returns Record Book. It is not necessary for one of the witnesses to be an Authorised Witness, but destruction may be arranged to take place at the same time as the destruction of stock CDs, in which case the authorised witness may be asked to oversee the destruction of patient returns. The Authorised Witness may do so if they have sufficient time available, but it is their decision and they are not obligated to do so (In practice, Community Pharmacists seldom ask us to witness the destruction of patient returns as they understand witnessed destruction is not required). If the Authorised Witness does oversee the destruction of patient returned CDs AND there is a need to make a note of a discrepancy/issue on the Controlled Drug Destruction Notes sheet, the AW must ensure that the patient is not identified, their initials however, should be included [if known] in case it subsequently became necessary to identify them. (V1.3) January 2009 (For Review December 2011) 10 of 11

Appendix 4 All authorised witnesses must read this SOP and sign the declaration below. I confirm that I have read, understood and will abide by the Destruction of Controlled Drugs by Authorised Witnesses Standard Operating Procedure. Date Name & Designation (please print) Signature (V1.3) January 2009 (For Review December 2011) 11 of 11